To describe survival following nosocomial bloodstream infections and quantify excess mortality associated with positive blood culture.
INTRODUCTION
In the premature infant, nosocomial bloodstream infections (NBSIs) are common and often fatal. Reports of NBSI in premature infants have largely concentrated on either single-center studies, or the experience of large academic medical centers. [1] [2] [3] [4] [5] [6] In this study, we evaluated risk factors associated with death following NBSI in a multicenter cohort of premature infants from 100 neonatal intensive care units (NICUs) . We also compared mortality in the blood culture positive and negative groups, and in that mortality comparison we controlled for prematurity, clinical presentation, and other risk factors.
Determining mortality due to NBSIs with a reliable gold standard is extremely difficult given the small proportion of neonates who undergo autopsy, so we also evaluated the proportion of infants who died within 7 days of blood culture acquisition and sought to calculate the excess fraction of mortality associated with positive blood cultures.
METHODS
Neonates eligible for inclusion in the study were discharged from 100 NICUs managed by Pediatrix Medical Group, Inc. These infants were born between September 1996 and December 2001, were r1250 g birthweight, and survived until at least the third day of life. The Pediatrix Group cared for 13,468 infants born with r1250 g birthweight; 7296 neonates did not have a blood culture after day of life 3, and 6172 did. This analysis was confined to blood cultures obtained after day of life 3.
With a database from a computer-assisted tool that generates clinical progress notes on neonates cared for by the Pediatrix Group, 7 we collected demographic data on birthweight, estimated gestational age (EGA), gender, race, and birthweight. We were also able to collect clinical data regarding the need for mechanical ventilation, corticosteroids, central vascular access, intralipids, and reported blood cultures obtained from each patient after day of life 3 until death or discharge. The unit of observation for this analysis was the neonate. Birthweight and EGA were evaluated as both categorical and continuous variables; and we evaluated race, gender, and clinical conditions at the time of culture including mechanical ventilation, intralipids, and vascular access as categorical variables. The outcome of interest was mortality after the first blood culture.
Blood culture result was a categorical variable. Of the 6172 infants, 5947 had a blood culture that was negative or specifically identified an organism in the blood. For 225 blood cultures, multiple organisms were grown or the organism was not speciated (identified only by Gram stain). In order to assure data quality, we limited the primary analysis to only those records with pathogenspecific information (we excluded those records identified only by Gram stain). We collapsed blood culture results into clinically relevant organism group categories F no growth, Gram-negative rod (GNR), coagulase negative staphylococcus (CONS), other Gram-positive organisms (GP-o), and Candida species. We then derived dummy variables for each organism group and used negative blood culture as the reference category. We used Cox proportional hazard modeling for the analysis.
Since there were 225 cultures excluded from the original analysis, we repeated the analysis using the Gram-stain results. In that analysis, the blood culture results that reported only Gramstain results were included in the regression analysis within the appropriate organism by Gram-stain category. We also repeated the analysis with multiple organisms grown as its own category. The repeated regression analyses did not differ from the results described in this article, so we elected to use the analysis of a single organism grown from the blood with species of organism identified as the cohort for this analysis.
We calculated the excess fraction as follows: (R 1 ÀR 0 )/R 1 , where R 1 is the risk of mortality in the exposed group, and R 0 is the risk of 7-day mortality in the unexposed group. We used 7-day mortality for the calculations of the excess fraction for both methodological and clinical reasons:
1. From a methodological standpoint, all neonates were followed until death or discharge. However, the amount of time from blood culture acquisition until discharge was variable (up to 330 days) . This open cohort design (variable length of time from blood culture to discharge) is not amenable to the calculation of the excess fraction. The vast majority of neonates (>98%) who had a blood culture and survived remained in the NICU for at least 7 days following a blood culture. 2. From a clinical standpoint, it is difficult to attribute mortality to a positive blood culture in a child if death occurs well after the blood culture occurs well before death F in some cases death occurred >100 days after the blood culture was obtained.
We conducted the analysis using SAS 8.02 (SAS Institute, Cary, NC); reported p-values are two-tailed and we used Wald 95% confidence intervals (CI). We used hazard ratios (HRs) to express measures of effect. The HR is the time-dependent instantaneous rate ratio, and is analogous to the odds ratio (OR) in logistic regression. HRs therefore have a similar interpretation of the strength of association. Thus, HR ¼ 1.0 (like OR ¼ 1.0) suggests no relationship. An HR ¼ 2.0 is interpreted like an OR ¼ 2.0. The exposed group (in this report, infants with a positive blood culture) has twice the risk of the unexposed group F infants with a negative blood culture, for example. A higher probability of survival will result in a lower hazard rate. Therefore, in a comparison of two groups of infants (positive blood culture and negative blood culture), the group that has a lower probability of survival will have an increased HR.
Permission to conduct the analysis without written informed consent was provided by the Duke University Institutional Review Board because the analysis was completed on data without identifiers.
RESULTS
The cohort consisted of 5947 infants weighing r1250 g birthweight. In all, 46% of the neonates were less than 27 weeks gestational age, 33% were >1000 g birthweight, 53% were male, and 50% were Caucasian. At the time of the acquisition of the first blood culture after the third day of life, 31% required mechanical ventilation, 53% had central vascular access, 37% were receiving intralipids, and 17% were receiving corticosteroids ( Table 1) .
The primary outcome for this study was mortality prior to discharge following first blood culture. The first blood culture after day of life 3 was negative for 4648/5947 (78%) of the neonates; 1299 neonates had a positive blood culture. Of the infants with a negative blood culture, 390/4648 (8%) died prior to discharge; and of the 1299 children with a positive blood culture, 136 (10%) died prior to discharge. Mortality was higher in children who had GNR bacteremia (19%) or candidemia (26%) than in those children with CONS bacteremia (8%) or GP-o bacteremia (6%). In fact, children with CONS or GP-o bacteremia had similar mortality as children with a negative blood culture (Figure 1 ).
In the regression modeling (Table 2) , we conducted Cox proportional hazards modeling with mortality prior to discharge as the outcome. In the unadjusted (bivariable) analysis, negative blood culture was referent and organism group was strongly associated with mortality. GNR bacteremia (HR ¼ 2.25; 95% CI ¼ 1.55, 3.26) and candidemia (HR ¼ 3.22; 95% CI ¼ 2.22, 4.68) were strongly associated with mortality. A positive blood culture for CONS (HR ¼ 0.92; 95% CI ¼ 0.72, 1.19) or GP-o (HR ¼ 0.74; 95% CI ¼ 0.40, 1.39) was not associated with subsequent mortality compared to a negative blood culture.
In the unadjusted analysis, younger gestational age and lower birthweight were associated with mortality; we also evaluated these two risk factors as continuous variables and the results were similar. As categorical variables often provide for a more meaningful interpretation for the physician, we present these risk factors in Table 2 in their categorical form. Unadjusted analysis also indicated that male neonates, neonates categorized as ''other'' race (>80% Hispanic, <10% each of Native American or Asian), neonates who required mechanical ventilation at the time of blood culture acquisition, and neonates who were receiving steroids at blood culture acquisition, had higher mortality. We also found that Benjamin et al. Mortality Following Nosocomial Bloodstream Infections neonates who were younger than day of life 10 when the blood culture was drawn also experienced greater mortality.
We then conducted multivariable analysis (adjusted analysis; Table 4 ). Our goal was to control for potential confounding variables (such as EGA) in examining the relationship between infecting organism and mortality.
In the multivariable analysis (Table 3) , infecting organism, day of life of blood culture acquisition, and EGA were the strongest risk factors to predict mortality. Compared to negative blood cultures, GNR bacteremia (HR ¼ 2.61) and candidemia (HR ¼ 2.27) were associated with mortality; however, bacteremia with CONS (HR ¼ 0.97) or GP-o (HR ¼ 1.08) was not associated with subsequent mortality. Other risk factors associated with mortality in the adjusted analysis were EGA (HR ¼ 2.44 for neonates EGA <25 weeks), age that culture was drawn (HR ¼ 3.39 for neonates day of life 3 to 10), and neonates classified as ''other'' race with greater mortality (HR ¼ 1.77).
Competing risks due to underlying morbidity associated with prematurity may be the etiology of mortality in children with a positive culture, so we also compared 7-day mortality and 30-day mortality following first culture in this cohort. These results are summarized in Table 4 . Again, mortality was higher in neonates bacteremic with GNR (12%) and those neonates that were candidemic (12%) than the mortality observed in neonates with a negative blood culture (2%), CoNS (2%), or GP-o (2%). The 7-day mortality excess fraction associated with positive blood culture was 50% [(0.04À0.02)/0.04], but the excess fraction varied substantially based on organism type. The 7-day mortality excess fraction for bacteremia due to CoNS or GP-o was 0 [(0.02À0.02)/ 0.02]. The 7-day mortality excess fraction for GNR bacteremia or candidemia was 83%.
DISCUSSION
Nosocomial infection is a leading cause of mortality in premature infants.
1,4-6 We sought to relate organism type isolated from the Figure 1 . Survival following first blood culture from 5497 neonates with birthweight r1250 g. The Kaplan-Meier graph is stratified by blood culture result: negative blood culture, GP-o Gram-negative organisms, and Candida; the y-axis is the proportion surviving.
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Benjamin et al. 2004; 24:175-180 blood to subsequent mortality in a diverse group of 100 NICUs. Mortality related to organisms isolated from the blood has been an increasing concern with the changing epidemiology of neonatal nosocomial BSI to a greater proportion of Gram-positive and multidrug-resistant Gram-negative organisms. 4, 5, 8 We observed a crude mortality following first blood culture (drawn after day of life 3) of 8%. When we stratified by blood culture result, we found this to be the mortality for those neonates whose blood culture was negative or grew GP-o; however, mortality was 19% for those neonates whose blood cultures grew Gramnegative organisms and 26% for those neonates infected with Candida species. In multivariable analysis, we found that isolation of only Gram-negative organisms and Candida species was associated with higher mortality than a negative blood culture.
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Our reports of the 7-day mortality excess fraction are novel for this study F most studies relating infection to mortality in neonatology have concentrated on presenting crude mortality rates following blood culture. In this study, we wanted to relate organism with mortality, yet take into account the reality that premature infants die from causes unrelated to sepsis. In light of the infrequency of autopsy completion in most neonates, there is no gold standard for relating infection to infection-related mortality.
We have estimated the infection-related mortality by calculating the 7-day mortality excess fraction. The excess fraction is also known as attributable risk percent, etiologic fraction, or attributable proportion. The excess fraction is a method by which investigators can estimate the proportion of disease in the exposed that is attributable to the exposure. This also represents the proportion of the disease in the exposed group that could be prevented by eliminating exposure. In this study, mortality was the 'disease' and organism type was the exposure. So this study suggests that substantial mortality is associated with GNR bacteremia and candidemia, but not with GPC bacteremia. Our results concerning the relationship between male gender, 9 race, 10 and increased mortality have been seen by previous investigators, but this is the first report from a large group of diverse NICU practice settings to report such associations.
The data we present have several substantial limitations. First, although the data were collected prospectively, they were collected primarily for clinical documentation rather than clinical research. Data collection was therefore not designed with the specific question we addressed, no power analysis was completed prior to the start of data collection, and therefore this study suffers from many of the limitations of a retrospective study. Further, the data could not be analyzed at the individual site level due to privacy and lack of informed consent. We could not therefore analyze the effects of any potential or confirmed ''outbreaks'' of nosocomial infections in this study. Third, autopsy results were not available for this study. Finally, these data do not address the morbidity associated with bacteremia. Positive blood cultures with GP-o are so common, that even a modest increase in morbidity associated with these organisms represents a great public health burden for premature infants.
The data we present have several strengths and most of them relate to the diversity of NICUs involved in the collection of data (see Acknowledgement section), the large sample size, and the ability of future investigators to use these data as a platform to design future clinical trials. For example: 1. These data are relevant to future study design in randomized interventional trials of the treatment of NBSIs: these data may be applied when planning a trial with mortality as the endpoint. 2. These data are also relevant to NBSI prevention with adjunctive therapies such as monoclonal or polyclonal antibodies.
Although the results from well-designed trials using IVIG to prevent neonatal nosocomial bacteremia have been mixed, 11, 12 such trials are now underway for products that specifically prevent Gram-positive bacteremia. 
